| GTO ID | GTC0810 |
| Trial ID | ChiCTR1900024457 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I study for the safety of different B-cell target cells in the treatment of recurrent and refractory mature B-cell lymphoma involving maxillofacial and / or central nervous system involvement |
| Year | 2019 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||
|
|||||||